Knobbe Martens Advises Conformal Medical on Definitive Agreement To Be Acquired by W. L. Gore & Associates
IRVINE, Calif., January, 8, 2026 – W. L. Gore & Associates, Inc. (Gore) a global materials science company dedicated to transforming industries and improving lives, announced this week that it...
An Obvious Solution to an Unknown Problem?
IMMUNOGEN, INC. v. STEWART Before Lourie, Dyk, and Prost. Appeal from the United States District Court for the Eastern District of Virginia. Summary: A solution to a problem can...
Getinge Acquires Paragonix Technologies
Getinge, a Swedish public limited company, announced on September 11, 2024 that it completed acquisition of Paragonix Technologies, Inc., a U.S. company specializing in organ transport products and services. According to Getinge’s press release, the total purchase price was $477 million.
Knobbe Martens Advises Paragonix Technologies in Definitive Agreement to be Acquired by Getinge
IRVINE, Calif., August 23, 2024 – Paragonix Technologies, a leading organ transplant company, announced today that it has entered into a definitive agreement to be acquired by Getinge. A team...
Ryan Newell and James Raleigh Recognized by USPTO For Pro Bono Work
IRVINE, Calif., May 23, 2024 – Knobbe Martens is proud to share that associates Ryan Newell and James Raleigh have been awarded the Patent Pro Bono Achievement Certificate by the...
In Westlaw Reuters Article, James Raleigh and Mitch Hadley Examine Copyright Rules Regarding AI Co-authored Comic Books
Knobbe Martens associate James Raleigh and partner Mitchell Hadley authored “Art of Ultron: AI looms over the comic book industry,” for Westlaw Reuters. In the article, Mr. Raleigh and Mr....
Ensuring a Reference Is Analogous Art to a Challenged Patent, Not to Another Reference
SANOFI-AVENTIS DEUTSCHLAND GMBH V. MYLAN PHARMACEUTICALS INC.
Before Reyna, Mayer, and Cunningham. Appeal from Patent Trial and Appeal Board.
Summary: When arguing that a reference is analogous prior art, a petitioner must show that the reference is analogous to the challenged patent, and not other prior art references.
Knobbe Martens Advises Signet Healthcare Partners in Leading $24 Million Series B Funding of Paragonix Technologies
Irvine, Calif., March 7, 2023 – Paragonix Technologies, Inc., a leading organ transplant company, today announced that it has secured $24 million in Series B funding, led by Signet Healthcare...